Rafferty Asset Management’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q3 | $2.74M | Sell |
11,754
-427
| -4% | -$98.7K | 0.01% | 517 |
|
|
2026
Q2 | $2.58M | Buy |
12,181
+3,683
| +43% | +$723K | 0.01% | 582 |
|
|
2026
Q1 | $1.67M | Sell |
8,498
-3,477
| -29% | -$676K | 0.01% | 647 |
|
|
2025
Q4 | $2.08M | Sell |
11,975
-441
| -4% | -$80.3K | 0.01% | 639 |
|
|
2025
Q3 | $2.37M | Buy |
12,416
+613
| +5% | +$109K | 0.01% | 612 |
|
|
2025
Q2 | $2.12M | Buy |
11,803
+1,524
| +15% | +$265K | 0.01% | 593 |
|
|
2025
Q1 | $1.74M | Sell |
10,279
-2,380
| -19% | -$391K | 0.01% | 613 |
|
|
2024
Q4 | $1.91M | Buy |
12,659
+1,368
| +12% | +$213K | 0.01% | 658 |
|
|
2024
Q3 | $1.75M | Sell |
11,291
-798
| -7% | -$119K | 0.01% | 674 |
|
|
2024
Q2 | $1.65M | Buy |
12,089
+636
| +6% | +$87.1K | 0.01% | 698 |
|
|
2024
Q1 | $1.52M | Buy |
11,453
+16
| +0.1% | +$2.08K | 0.01% | 754 |
|
|
2023
Q4 | $1.58M | Sell |
11,437
-286
| -2% | -$37.6K | 0.01% | 731 |
|
|
2023
Q3 | $1.43M | Buy |
11,723
+880
| +8% | +$117K | 0.01% | 707 |
|
|
2023
Q2 | $1.52M | Buy |
10,843
+911
| +9% | +$126K | 0.01% | 718 |
|
|
2023
Q1 | $1.41M | Buy |
9,932
+132
| +1% | +$18.9K | 0.01% | 710 |
|
|
2022
Q4 | $1.53M | Buy |
9,800
+3,568
| +57% | +$513K | 0.01% | 646 |
|
|
2022
Q3 | $765K | Buy |
6,232
+3,384
| +119% | +$446K | 0.01% | 755 |
|
|
2022
Q2 | $379K | Sell |
2,848
-789
| -22% | -$108K | ﹤0.01% | 844 |
|
|
2022
Q1 | $498K | Sell |
3,637
-487
| -12% | -$67.9K | ﹤0.01% | 1000 |
|
|
2021
Q4 | $713K | Buy |
4,124
+227
| +6% | +$34.5K | ﹤0.01% | 994 |
|
|
2021
Q3 | $566K | Buy |
3,897
+994
| +34% | +$145K | ﹤0.01% | 1019 |
|
|
2021
Q2 | $383K | Buy |
2,903
+145
| +5% | +$19K | ﹤0.01% | 1122 |
|
|
2021
Q1 | $354K | Buy |
2,758
+179
| +7% | +$22.1K | ﹤0.01% | 1043 |
|
|
2020
Q4 | $307K | Sell |
2,579
-238
| -8% | -$29K | ﹤0.01% | 802 |
|
|
2020
Q3 | $323K | Sell |
2,817
-9,508
| -77% | -$1.12M | ﹤0.01% | 792 |
|
|
2020
Q2 | $1.4M | Buy |
+12,325
| New | +$1.31M | 0.02% | 450 |
|
|
2020
Q1 | – | Sell |
-3,638
| Closed | -$389K | – | 652 |
|
|
2019
Q4 | $389K | Buy |
+3,638
| New | +$379K | 0.01% | 735 |
|
|
2014
Q3 | – | Sell |
-6,654
| Closed | -$391K | – | 372 |
|
|
2014
Q2 | $391K | Buy |
+6,654
| New | +$390K | 0.08% | 190 |
|
Other funds holding DGX
Rafferty Asset Management's DGX Position: Q3 2026 in Review
Rafferty Asset Management reduced its Quest Diagnostics (DGX) stake by 3.5% in Q3 2026, selling an estimated $98.7K and leaving 11,754 shares worth $2.74M. The position accounts for 0.01% of the portfolio, ranked #517.
Rafferty Asset Management first reported a position in DGX in Q2 2014 and has held it in 28 quarters since. 1,142 funds tracked by Wall St. Rank hold DGX as of Q3 2026.
- Rafferty Asset Management held 11,754 shares of Quest Diagnostics worth $2.74M as of Q3 2026.
- Rafferty Asset Management sold 427 Quest Diagnostics shares in Q3 2026, an estimated $98.7K.
- Quest Diagnostics made up 0.01% of Rafferty Asset Management's portfolio in Q3 2026, its #517 holding.
- Rafferty Asset Management first reported a position in Quest Diagnostics in Q2 2014 and has held it in 28 quarters since.
- 1,142 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2026.
Based on Rafferty Asset Management's 13F filing for Q3 2026, filed 13 Nov 2026.